Venlafaxine Hydrochloride
Product Images NDC 50090-3855

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-3855). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (A7f843b6 0935 4be6 A465 97179a846148 01)

FDA Label Image

Figure 2 (A7f843b6 0935 4be6 A465 97179a846148 02)

FDA Label Image

Figure 3 (A7f843b6 0935 4be6 A465 97179a846148 03)

This text describes recommendations for dosage adjustments in patients with specific health conditions or demographic characteristics. The recommendations include changes to the maximum concentration (Cmax) and area under the curve (AUC) for various analytes in populations with hepatitis (cirrhosis, mild and moderate impairment), renal impairment, and fenar emostarysie. There are also recommendations for patients with age (60 years and older) and gender differences. The text provides percentages for dose adjustments for each population and analyte.*

FDA Label Image

Structure (A7f843b6 0935 4be6 A465 97179a846148 04)

FDA Label Image

Logo (A7f843b6 0935 4be6 A465 97179a846148 05)

FDA Label Image

Logo (A7f843b6 0935 4be6 A465 97179a846148 06)

FDA Label Image

Label Image (Lbl500903855)

This appears to be a list of medications. Venlafaxine and Hydrochlorothiazide are two separate medications, and the text describes a container of 50 extended-release capsules.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.